{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:36:12Z","timestamp":1773329772264,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"National Institution of Health"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.intimp.2015.06.025","type":"journal-article","created":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T03:47:30Z","timestamp":1435722450000},"page":"354-358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Optimization of experimental conditions for functional in vitro characterization of humanized antibodies specific for staphylococcal enterotoxin B"],"prefix":"10.1016","volume":"28","author":[{"given":"Jennifer L.","family":"MacIntyre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avanish K.","family":"Varshney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Gatto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarence","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelvin","family":"Kerns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleg","family":"Kovalenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karissa","family":"Adkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Zollner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina C.","family":"Fries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fergus R.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2015.06.025_bb0005","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4161\/mabs.2.3.11782","article-title":"Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies","volume":"2","author":"Brennan","year":"2010","journal-title":"MAbs"},{"issue":"6","key":"10.1016\/j.intimp.2015.06.025_bb0010","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1034\/j.1398-9995.2000.00432.x","article-title":"Severe atopic dermatitis is associated with sensitization to staphylococcal enterotoxin B (SEB)","volume":"55","author":"Breuer","year":"2000","journal-title":"Allergy"},{"issue":"20","key":"10.1016\/j.intimp.2015.06.025_bb0015","doi-asserted-by":"crossref","first-page":"9036","DOI":"10.1073\/pnas.88.20.9036","article-title":"Identification of the Fc gamma receptor class I binding site in human IgG through the use of recombinant IgG1\/IgG2 hybrid and point-mutated antibodies","volume":"88","author":"Chappel","year":"1991","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"10.1016\/j.intimp.2015.06.025_bb0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1476-8518-8-9","article-title":"Generation and characterization of high affinity human monoclonal antibodies that neutralize staphylococcal enterotoxin B","volume":"8","author":"Drozdowski","year":"2010","journal-title":"J. Immune Based Ther. Vaccines"},{"issue":"10","key":"10.1016\/j.intimp.2015.06.025_bb0025","doi-asserted-by":"crossref","first-page":"e13253","DOI":"10.1371\/journal.pone.0013253","article-title":"Inhibition of toxic shock by human monoclonal antibodies against staphylococcal enterotoxin B","volume":"5","author":"Larkin","year":"2010","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.intimp.2015.06.025_bb0030","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.addr.2005.01.017","article-title":"Vaccines against the category B toxins: staphylococcal enterotoxin B, epsilon toxin and ricin","volume":"57","author":"Mantis","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"10.1016\/j.intimp.2015.06.025_bb0035","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1128\/IAI.01121-09","article-title":"Potent neutralization of staphylococcal enterotoxin B by synergistic action of chimeric antibodies","volume":"78","author":"Tilahun","year":"2010","journal-title":"Infect Immun"},{"issue":"1-2","key":"10.1016\/j.intimp.2015.06.025_bb0040","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00604-009-0171-1","article-title":"Surface plasmon resonance-based immunosensor with oriented immobilized antibody fragments on a mixed self-assembled monolayer for the determination of staphylococcal enterotoxin B","volume":"166","author":"Tsai","year":"2009","journal-title":"Microchim Acta"},{"issue":"6","key":"10.1016\/j.intimp.2015.06.025_bb0045","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/infdis\/jiu198","article-title":"Humanized staphylococcal enterotoxin B (SEB)-specific monoclonal antibodies protect from SEB intoxication and Staphylococcus aureus infections alone or as adjunctive therapy with vancomycin","volume":"210","author":"Varshney","year":"2014","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.intimp.2015.06.025_bb0050","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/infdis\/jit421","article-title":"Staphylococcal enterotoxin B-specific monoclonal antibody 20B1 successfully treats diverse Staphylococcus aureus infections","volume":"208","author":"Varshney","year":"2013","journal-title":"J Infect Dis"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576915003240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576915003240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:40:38Z","timestamp":1762551638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576915003240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1567576915003240"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2015.06.025","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of experimental conditions for functional in vitro characterization of humanized antibodies specific for staphylococcal enterotoxin B","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2015.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}